Ehst B, Han G, Guenthner S, Eads K, Jacobson A. Long-term Efficacy and Safety of Brodalumab in Patients With Psoriasis Disease Duration <10 and ≥10 Years: Analysis of Two Phase 3 Studies. J of Skin [Internet]. 2019Nov.9 [cited 2024Jul.3];3:S25. Available from: https://jofskin.org/index.php/skin/article/view/752